CrushSCI.com
177.6Average days
164.5Median days
7Fastest days
356Longest days
1802025 publications

Paper Review Records

All Paper Review Records

28 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

356 days

TIM ‐3 Functions as an Activator of NK Cells in GBM and Can Be Upregulated by Torin‐1: Implications for Exogenous NK Cell Transplantation

Authors
Yuning Liu; Tram Dao; Shambhavi Borde; Diana Dinh; Sofia Lombardi; Sandra Torregrosa‐Allen; Haley A. Harper; Veronika Slivova; Aaron Cohen‐Gadol; MacKenzie McIntosh; Bennet D. Elzey; Sandro MatosevicShow moreShow less
Affiliations
1. Department of Industrial and Molecular Pharmaceutics Purdue University West Lafayette Indiana USA; 2. Institute for Cancer Research Purdue University West Lafayette Indiana USA; 3. Enterprise Clinical Research Operations Biorepository Indiana University Health Indianapolis Indiana USA; 4. ATLAS Institute of Brain and Spine, Neurosurgical Atlas and Cedars‐Sinai Medical Center Department of Neurosurgery Los Angeles California USA; 5. Histology Research Laboratory, Center for Comparative Translational Research, College of Veterinary Medicine Purdue University West Lafayette Indiana USA; 6. Department of Comparative Pathobiology Purdue University West Lafayette Indiana USAShow moreShow less
Source PDF DOI Publisher page
217 days

Yin‐Yang: The Dual Role of Lactate as a Context‐Dependent Immunometabolic Regulator in the Inflammatory Microenvironment

Authors
Shihan Wang; Peirong Gan; Ya Chen; Beibei Yang; Tao Ding; Hong WuShow moreShow less
Affiliations
1. College of Pharmacy, Anhui University of Chinese Medicine Hefei China; 2. Key Laboratory of Xin'an Medicine, Ministry of Education Anhui University of Chinese Medicine Hefei China; 3. Anhui Provincial Key Laboratory of Chinese Medicinal Formula Hefei ChinaShow moreShow less
Source PDF DOI Publisher page
146 days

CCAT1 Enhances NK Cells‐Mediated Antitumor Immunity in Hepatocellular Carcinoma

Authors
Changke Pu; Gaoxiong Tan; Deren Yang; Chuan Tan; Wenyong Feng; Zhaolin Pan; Anmin Wang; Jiajie Lin; Chen Deng; Huamei Wei; Jian PuShow moreShow less
Affiliations
1. Department of Clinical Laboratory Affiliated Hospital of Youjiang Medical University for Nationalities Baise China; 2. Graduate College of Youjiang Medical University for Nationalities Baise China; 3. The First Clinical Medical College of Jinan University Guangzhou China; 4. Department of Hepatobiliary Surgery Affiliated Hospital of Youjiang Medical University for Nationalities Baise China; 5. Guangxi Clinical Medical Research Center of Hepatobiliary Disease Baise China; 6. Department of Orthopedics Affiliated Hospital of Youjiang Medical University for Nationalities Baise China; 7. Guangxi Zhuang Autonomous Region Engineering Research Center for Biomaterials in Bone and Joint Degenerative Diseases Baise China; 8. Norman Bethune International Institute of Canada for Healthcare Innovation Toronto Ontario Canada; 9. Department of Pathology Affiliated Hospital of Youjiang Medical University for Nationalities Baise ChinaShow moreShow less
Source PDF DOI Publisher page
162 days

ADAM9 Regulation of CXCL12 ‐Dependent Myeloid‐Derived Suppressor Cells Shifting the Immune Landscape of Lung Adenocarcinoma

Authors
Jing‐Pei Liu; Wan‐Ling Wu; Kuan‐Yin Shen; Ting‐Ting Kuo; Yu‐Kai Huang; Wei‐Chung Cheng; Ching‐Chan Lin; Shih‐Jen Liu; Yuh‐Pyng SherShow moreShow less
Affiliations
1. Graduate Institute of Biomedical Sciences China Medical University Taichung Taiwan; 2. National Institute of Infectious Diseases and Vaccinology National Health Research Institutes Miaoli Taiwan; 3. Center for Molecular Medicine China Medical University Hospital Taichung Taiwan; 4. Program for Cancer Biology and Drug Discovery China Medical University Taichung Taiwan; 5. Division of Hematology and Oncology China Medical University Hospital Taichung Taiwan; 6. Graduate Institute of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan; 7. Institute of Biochemistry and Molecular Biology China Medical University Taichung Taiwan; 8. Cancer Biology and Precision Therapeutics Center China Medical University Taichung TaiwanShow moreShow less
Source PDF DOI Publisher page
7 days

A Look Ahead for Immunology

Authors
Greg M. DelgoffeShow moreShow less
Affiliations
1. Department of Immunology University of Pittsburgh Pittsburgh Pennsylvania USAShow moreShow less
Source PDF DOI Publisher page
259 days

IL ‐6/ IL ‐ 6R ‐Mediated Mechanisms in Lung Cancer: From Pathogenesis to Potential Therapeutic Targets

Authors
Qamar Abuhassan; Hamzeh J. Al‐Ameer; S. Renuka Jyothi; Priya Priyadarshini Nayak; P. Prakash; Gunjan Mukherjee; Aashna Sinha; Ozoda HazratkulovaShow moreShow less
Affiliations
1. Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy University of Jordan Amman Jordan; 2. Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan; 3. Department of Biotechnology and Genetics, School of Sciences JAIN (Deemed To Be University) Bangalore Karnataka India; 4. Department of Medical Oncology IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed To Be University) Bhubaneswar Odisha India; 5. Department of Biotechnology Sathyabama Institute of Science and Technology Chennai Tamil Nadu India; 6. University Institute of Biotechnology, Chandigarh University Mohali Punjab India; 7. School of Applied and Life Sciences, Division of Research and Innovation Uttaranchal University Dehradun Uttarakhand India; 8. Department of Medicine Termez University of Economics and Service Termez UzbekistanShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.